GSK beat fourth-quarter profit and sales forecasts helped by sales of its shingles vaccine and unveiled an upbeat forecast for 2023. Meanwhile, Novartis said it’s full-year core operating income was broadly flat, and below expectations, at $16.7 billion https://t.co/rckUBnxFEr pic.twitter.com/CccKRFliTB— Reuters (@Reuters) February 1, 2023
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)